Advertisement

Fragments of cell-free DNA increase transcription in human mesenchymal stem cells, activate TLR-dependent signal pathway, and suppress apoptosis

  • S. V. Kostyuk
  • E. M. Malinovskaya
  • A. V. Ermakov
  • T. D. Smirnova
  • L. V. Kameneva
  • O. V. Chvartatskaya
  • P. A. Loseva
  • E. S. Ershova
  • L. N. Lyubchenko
  • N. N. Veiko
Article

Abstract

Human mesenchymal stem cells (MSCs) are widely used in regenerative medicine. However, many questions on the role of different signaling pathways in the regulation of stem cell (SC) functional activity within the organism still remain unanswered. In lesion regions the level of cell death increases and DNA fragments from dead cells (cell-free DNA, cfDNA) are accumulated in blood. We have shown that in vitro contact of adipose-derived MSCs with cfDNA fragments the increase of transcription activity (evaluated by the increase of total cellular RNA and rRNA) is observed. GC-rich cfDNA fragments (GC-DNA) activated the TLR9-dependent signal pathway causing up-regulation of expression of TLR9 and MyD88, the TLR9-signaling pathway adapter. AT-rich DNA fragments did not increase the TLR9 expression, but did increase the level of MyD88 mRNA. So we suggest that AT-DNA acts via some other receptors, which, nevertheless, activate MyD88-dependent signalling in MSCs. We have also shown that cfDNA fragments decreased the activity of caspase, an apoptotic enzyme. Thus, cfDNA can significantly influence the functional activity of MSC by activating the TLR9- and MyD88-dependent signal pathways and by lowering the apoptosis level.

Keywords

mesenchymal stem cells cell-free DNA TLR9 apoptosis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Morrison, S.J. and Kimble, J., Nature, 2006, vol. 441, no. 7097, pp. 1068–1074.CrossRefGoogle Scholar
  2. 2.
    Stagg, J., Tissue Antigens, 2007, no. 1, pp. 1–9.Google Scholar
  3. 3.
    Lehrer, M.S., Sun, T.T., and Lavker, R.M., J. Cell Sci., 1998, vol. 111, pp. 2867–2875.Google Scholar
  4. 4.
    Ermakov, A.V., Konkova, M.S., Kostyuk, S.V., Egolina, N.A., Efremova, L.V., and Veiko, N.N., Mutat. Res., 2009, vol. 669, pp. 155–161.CrossRefGoogle Scholar
  5. 5.
    Veiko, N.N., Ivanova, S.M., Kostyuk, S.V., Shubaeva, N.O., Ermakov, A.I., Egolina, N.F., Ryazantseva, T.F., and Speransky, A.I., Immunologiya, 2007, vol. 28, no. 3, pp. 147–151.Google Scholar
  6. 6.
    Pisetsky, D.S., Rheum. Dis. Clin. North. Am., 2004, vol. 30, pp. 575–587.CrossRefGoogle Scholar
  7. 7.
    Choi, J.J., Reich, C.F., and Pisetskym D.S., Immunology, 2005, vol. 115, pp. 55–62.CrossRefGoogle Scholar
  8. 8.
    van der Vaart, M. and Pretorius, P.J., Ann N. Y. Acad. Sci., 2008, vol. 1137, pp. 18–26.CrossRefGoogle Scholar
  9. 9.
    Kostyuk, S.V., Zamulaeva, I.A., Agapova, R.K., Ermakov, A.V., Saenko, A.S., Orlova, N.V., Smirnova, S.G., Veiko, N.N., and Spitkovsky, D.M., Radiat. Biol. Radioekol., 2008, vol. 48, no. 1, pp. 5–13.Google Scholar
  10. 10.
    Bulicheva, N., Veiko, N., Fidelina, O., Mkrtumova, N., and Neverova, M., Clinical Chemistry, 2007, vol. 53, no. 10 (Abstracts for CNAPS V), pp. 15–16.Google Scholar
  11. 11.
    Fan, H.C., Blumenfeld, Y.J., Chitkara, U., Hudgins, L., and Quake, S.R., Proc. Natl. Acad. Sci. USA, 2008, vol. 105, pp. 16266–16271.CrossRefGoogle Scholar
  12. 12.
    Pevsner-Fischer, M., Morad, V., Cohen-Sfady, M., Rousso-Noori, L., Zanin-Zhorov, A., Cohen, S., Cohen, I.R., and Zipori, D., Blood, 2007, vol. 109, pp. 1422–1432.CrossRefGoogle Scholar
  13. 13.
    Fink, T., Lund, P., Pilgaard, L., Rasmussen, J.G., Duroux, M., and Zachar, V., BMC Mol. Biol., 2008, vol. 9, p. 98CrossRefGoogle Scholar
  14. 14.
    Veiko, N.N. and Spitkovsky, D.M., Radiat. Biol. Radioekol., 2000, vol. 40, pp. 396–404.Google Scholar
  15. 15.
    Veiko, N.N., Shubaeva, N.O., Ivanova, S.N., Speransky, A.I., Lyapunova, N.A., and Spitkovsky, D.M., Byull. Eksper. Biol. Med., 2006, vol. 142, no. 3, pp. 313–316.CrossRefGoogle Scholar
  16. 16.
    Magnusson, M., Tobes, R., Sancho, J., and Pareja, E., J. Immunol., 2007, vol. 179, pp. 31–35.Google Scholar
  17. 17.
    Morrison, S.J. and Spradling, A.C., Cell, 2008, vol. 132, pp. 598–611.CrossRefGoogle Scholar
  18. 18.
    Potten, C.S., Wilson, J.W., and Booth, C., Stem Cells, 1997, vol. 15, no. 2, pp. 82–93.CrossRefGoogle Scholar
  19. 19.
    Wang, Z.J., Zhang, F.M., Wang, L.S., Yao, Y.W., Zhao, Q., and Gao, X., Cell Biol. Int., 2009, vol. 33, pp. 665–674.CrossRefGoogle Scholar
  20. 20.
    Moro, L., Venturino, M., Bozzo, C., Silengo, L., Altruda, F., Beguinot, L., Tarone, G., and Defilippi, P., EMBO J., 1998, vol. 17, pp. 6622–6632.CrossRefGoogle Scholar
  21. 21.
    Zhang, Z., Vuori, K., Reed, J.C., and Ruoslahti, E., Proc. Natl. Acad. Sci. USA, 1995, vol. 92, pp. 6161–6165.CrossRefGoogle Scholar
  22. 22.
    Reginato, M.J., Mills, K.R., Paulus, J.K., Lynch, D.K., Sgroi, D.C., Debnath, J., Muthuswamy, S.K., and Brugge, J.S., Nat. Cell Biol., 2003, vol. 5, pp. 733–740.CrossRefGoogle Scholar
  23. 23.
    Armstrong, L., Hughes, O., Yung, S., et al., Hum. Mol. Genet., 2006, vol. 15, pp. 1894–1913.CrossRefGoogle Scholar
  24. 24.
    Shawber, C., Nofziger, D., Hsieh, J.J., Lindsell, C., Bögler, O., Hayward, D., and Weinmaster, G., Development, 1996, vol. 122, pp. 3765–3773.Google Scholar

Copyright information

© Pleiades Publishing, Ltd. 2012

Authors and Affiliations

  • S. V. Kostyuk
    • 1
  • E. M. Malinovskaya
    • 1
  • A. V. Ermakov
    • 1
  • T. D. Smirnova
    • 1
  • L. V. Kameneva
    • 1
  • O. V. Chvartatskaya
    • 1
  • P. A. Loseva
    • 1
  • E. S. Ershova
    • 1
  • L. N. Lyubchenko
    • 2
  • N. N. Veiko
    • 1
  1. 1.Research Centre for Medical GeneticsRussian Academy of Medical SciencesMoscowRussia
  2. 2.Blokhin Cancer Research CenterRussian Academy of Medical SciencesMoscowRussia

Personalised recommendations